Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants
Stopped early · Phase 2 · Has a placebo group
Conditions studied: SARS-CoV-2
In brief
The study evaluated the safety, tolerability, reactogenicity, and effectiveness of mRNA-1273.214 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in infants aged 12 weeks to \< 6 months.
Key facts
- Study ID
- NCT05584202
- Run by
- ModernaTX, Inc.
- People needed
- 68
- Starts
- 2022-09-30
- Expected to finish
- 2024-11-15
- Last updated by the study team
- 2025-11-26
Who can join
Age: 0 and older, up to 1. Sex: any. Healthy volunteers: accepted.
Where it is running
- Trinity Clinical Research, LLC - Bessemer — Bessemer, Alabama, United States
- UAB Pediatrics — Birmingham, Alabama, United States
- Eclipse Clinical Research — Tucson, Arizona, United States
- Madera Family Medical Group — Madera, California, United States
- SeraCollection Research Services LLC — Montebello, California, United States
- Center For Clinical Trials LLC — Paramount, California, United States
- Children's Hospital Colorado — Aurora, Colorado, United States
- Meridian Clinical Research (Washington) - PPDS — Washington D.C., District of Columbia, United States
- PAS Research — Clearwater, Florida, United States
- Prohealth Research Center — Doral, Florida, United States
- University of Florida Jackonsville — Jacksonville, Florida, United States
- Kissimmee Clinical Research — Kissimmee, Florida, United States
- Acevedo Clinical Research — Miami, Florida, United States
- D&H National Research Centers — Miami, Florida, United States
- Suncoast Research Associates LLC - ERN - PPDS — Miami, Florida, United States
- Excellence Medical and Research LLC — Miami Gardens, Florida, United States
- KM International Research Operation - Saint Cloud — Saint Cloud, Florida, United States
- PAS Research — Tampa, Florida, United States
- Emory University School of Medicine — Atlanta, Georgia, United States
- Medical Research Partners- Ammon — Ammon, Idaho, United States
- MedPharmics - Platinum - PPDS — Covington, Louisiana, United States
- MedPharmics - Platinum - PPDS — Lafayette, Louisiana, United States
- UMass Memorial Medical Center — Worcester, Massachusetts, United States
- Clinical Research Institute, Inc — Minneapolis, Minnesota, United States
- Be Well Clinical Studies — Lincoln, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.